Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
J Subst Abuse Treat ; 141: 108849, 2022 10.
Article in English | MEDLINE | ID: mdl-35932759

ABSTRACT

INTRODUCTION: Nonpharmaceutical fentanyl has reconfigured the U.S. illicit drug market, contributing to a drastic increase in overdose drug deaths. While illicit fentanyl has subsumed the drug supply in the Northeast and Midwest, it has more recently reached the West. For this study, we explored knowledge, attitudes, and behaviors among people who use drugs in Oregon in the context of the emergence of fentanyl in the drug supply. METHODS: We conducted in-depth interviews by phone with 34 people who use drugs in Oregon from May to June 2021. We used thematic analysis to analyze transcripts and construct themes. RESULTS: People who use drugs knew about fentanyl, expressed doubt that fentanyl could be found in methamphetamine; believed those who were younger or less experienced were at higher risk for harm; and received information about fentanyl from drug dealers, syringe service programs, or peers (other people who use drugs). Preference for fentanyl's presence in drugs like heroin or methamphetamine was mixed. Some felt that their preference was irrelevant since fentanyl was unavoidable. Participants reported engaging in harm reduction practices, including communicating about fentanyl with dealers and peers, testing for fentanyl, using smaller quantities of drugs, switching from injecting to smoking, and using naloxone. CONCLUSION: People who use drugs are responding to the rise of fentanyl on the West Coast and are concerned about the increasing uncertainty and hazards of the drug supply. They are willing and motivated to adopt harm reduction behaviors. Harm reduction promotion from syringe service programs and public health agencies is essential to reduce injury and death from nonpharmaceutical fentanyl.


Subject(s)
Drug Overdose , Methamphetamine , Analgesics, Opioid , Drug Overdose/prevention & control , Fentanyl , Health Knowledge, Attitudes, Practice , Humans , Oregon
2.
J Addict Med ; 16(6): 695-701, 2022.
Article in English | MEDLINE | ID: mdl-35797436

ABSTRACT

OBJECTIVES: The objective of this study was to examine COVID-19 vaccination acceptance and explore reasons for COVID-19 vaccine hesitancy among people who use drugs (PWUDs), a population with increased COVID-19 transmission and morbidity. METHODS: We conducted semi-structured in-depth interviews with PWUDs in 7 Oregon counties from May 11 to June 25, 2021. Participants (n = 34) were recruited in partnership with syringe service programs and local community organizations staff, participant-referrals, and flyer advertising. Research staff conducted interviews via telephone to assess participants' acceptance of the COVID-19 vaccine, find knowledge gaps where new educational information about vaccination would be helpful, and identify who would be perceived as a trustworthy source of information. Interviews were transcribed and coded using thematic analysis with a deductive approach. RESULTS: Most participants had not received the COVID-19 vaccine and were not planning on or were unsure about receiving it. Participants were mistrustful of the rapid COVID-19 vaccine development process, the agencies involved in the development, and vaccines in general. Participants shared varied and contrasting responses about who they would trust to provide information about the COVID-19 vaccine, including peer recovery support specialists, doctors, or other health care professionals, and specified federal agencies or media outlets. CONCLUSIONS: As addiction medicine and public health staff continue to respond to the evolving impacts of COVID-19, vaccination planning should be tailored to the unique needs of PWUD to increase COVID-19 vaccine acceptance in this high-risk population.


Subject(s)
COVID-19 Vaccines , COVID-19 , Humans , COVID-19/prevention & control , Oregon/epidemiology , Vaccination , Health Personnel
3.
Harm Reduct J ; 19(1): 76, 2022 07 11.
Article in English | MEDLINE | ID: mdl-35818072

ABSTRACT

BACKGROUND: Illicit fentanyl has contributed to a drastic increase in overdose drug deaths. While fentanyl has subsumed the drug supply in the Northeastern and Midwestern USA, it has more recently reached the Western USA. For this study, we explored perspectives of people who use drugs (PWUD) on the changing drug supply in Oregon, experiences of and response to fentanyl-involved overdose, and recommendations from PWUD to reduce overdose risk within the context of illicit fentanyl's dramatic increase in the recreational drug supply over the past decade. METHODS: We conducted in-depth interviews by phone with 34 PWUD in Oregon from May to June of 2021. We used thematic analysis to analyze transcripts and construct themes. RESULTS: PWUD knew about fentanyl, expressed concern about fentanyl pills, and were aware of other illicit drugs containing fentanyl. Participants were aware of the increased risk of an overdose but remained reluctant to engage with professional first responders due to fear of arrest. Participants had recommendations for reducing fentanyl overdose risk, including increasing access to information, harm reduction supplies (e.g., naloxone, fentanyl test strips), and medications for opioid use disorder; establishing drug checking services and overdose prevention sites; legalizing and regulating the drug supply; and reducing stigma enacted by healthcare providers. CONCLUSION: PWUD in Oregon are aware of the rise of fentanyl and fentanyl pills and desire access to tools to reduce harm from fentanyl. As states in the Western USA face an inflection point of fentanyl in the drug supply, public health staff, behavioral health providers, and first responders can take action identified by the needs of PWUD.


Subject(s)
Drug Overdose , Fentanyl , Illicit Drugs , Opiate Overdose , Opioid-Related Disorders , Analgesics, Opioid/adverse effects , Drug Overdose/prevention & control , Fentanyl/adverse effects , Humans , Oregon
4.
BJPsych Bull ; 46(1): 10-15, 2022 Feb.
Article in English | MEDLINE | ID: mdl-33583477

ABSTRACT

AIMS AND METHOD: To explore whether people from Black, Asian and minority ethnic (BAME) communities experience equality of access and outcome in individual placement and support (IPS) employment services. Cross-sectional data were analysed of all people with severe mental health problems who accessed two mature high-fidelity IPS services in London in 2019 (n = 779 people). RESULTS: There were no significant differences between the proportions of people who gained employment. The data strongly suggest that people from BAME communities are not differentially disadvantaged in relation to either access to or outcomes of IPS employment services. CLINICAL IMPLICATIONS: The challenge for mental health professionals is not to decide who can and who cannot work but, how to support people on their case-loads to access IPS and move forward with life beyond their illness.

5.
Nurs Econ ; 22(4): 193-5, 175, 2004.
Article in English | MEDLINE | ID: mdl-15382394

ABSTRACT

Nursing leaders in ambulatory care need to objectively quantify patient intensity to balance patient care needs and nursing resources. The day-to-day application of the Ambulatory Intensity System (AIS) is illustrated in this final article of a three-part series that reviewed current literature on acuity/intensity tools, and described the development of an AIS system to objectively quantify the nursing care.


Subject(s)
Ambulatory Care/organization & administration , Cancer Care Facilities/organization & administration , Nurse Administrators/organization & administration , Nursing Staff, Hospital/organization & administration , Oncology Nursing/organization & administration , Health Resources , Humans , Models, Nursing , Needs Assessment , Nursing Administration Research , Nursing Assessment , Nursing Evaluation Research , Pilot Projects , Severity of Illness Index , United States
6.
Nurs Econ ; 22(3): 120-3, 107, 2004.
Article in English | MEDLINE | ID: mdl-15211914

ABSTRACT

Nursing leaders in ambulatory care need to objectively quantify patient intensity to balance patient care needs and nursing resources. In this three-part series, current literature on acuity/intensity tools will be reviewed, and the development of an Ambulatory Intensity System (AIS) to objectively quantify nursing care will be described. In this article, the ongoing implementation of the system, its incorporation into the organization's established computerized appointment system, reliability measures, and related performance improvement activities will be discussed.


Subject(s)
Ambulatory Care Facilities/statistics & numerical data , Ambulatory Care Information Systems , Oncology Nursing/organization & administration , Outpatients/classification , Workload/statistics & numerical data , Ambulatory Care Facilities/organization & administration , Appointments and Schedules , Attitude to Computers , Humans , Personnel Staffing and Scheduling , Severity of Illness Index
7.
Nurs Econ ; 22(2): 58-63, 55, 2004.
Article in English | MEDLINE | ID: mdl-15108473

ABSTRACT

Nursing leaders in ambulatory care need to objectively quantify patient intensity to balance patient care needs and nursing resources. In this three-part series the current literature on acuity/intensity tools will be reviewed, and the development of an Ambulatory Intensity System (AIS) to objectively quantify the nursing care will be described.


Subject(s)
Ambulatory Care/organization & administration , Cancer Care Facilities/organization & administration , Nurse's Role , Nursing Staff, Hospital/organization & administration , Oncology Nursing/organization & administration , Delivery of Health Care, Integrated/organization & administration , Humans , Models, Nursing , Nursing Administration Research , Nursing Assessment , Nursing Evaluation Research , Pilot Projects , Severity of Illness Index , United States
SELECTION OF CITATIONS
SEARCH DETAIL
...